LENZ THERAPEUTICS INC (LENZ) Stock Analyst Ratings
USA - NASDAQ:LENZ - US52635N1037 - Common Stock
25.6 USD
-0.89 (-3.36%)
25.6 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 87% to LENZ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 54.5. This target is 112.88% above the current price.
LENZ was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about LENZ.
In the previous month the buy percentage consensus was at a similar level.
LENZ was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-20 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-10-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-01 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-31 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-07-31 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-20 | Citigroup | Maintains | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-27 | Raymond James | Initiate | Outperform |
| 2024-08-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Initiate | Buy |
| 2024-04-15 | Leerink Partners | Initiate | Outperform |
| 2024-04-15 | William Blair | Initiate | Outperform |
| 2024-04-10 | Citigroup | Initiate | Buy |
| 2024-03-27 | Piper Sandler | Initiate | Overweight |
LENZ THERAPEUTICS INC / LENZ FAQ
Can you provide the average price target for LENZ THERAPEUTICS INC stock?
14 analysts have analysed LENZ and the average price target is 54.5 USD. This implies a price increase of 112.88% is expected in the next year compared to the current price of 25.6.
What is the consensus rating for LENZ stock?
The consensus rating for LENZ THERAPEUTICS INC (LENZ) is 87.1429 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for LENZ THERAPEUTICS INC stock?
The number of analysts covering LENZ THERAPEUTICS INC (LENZ) is 14.